InvestorsHub Logo
Followers 825
Posts 119410
Boards Moderated 16
Alias Born 09/05/2002

Re: Boing x 2 post# 17800

Tuesday, 10/10/2017 1:59:15 PM

Tuesday, October 10, 2017 1:59:15 PM

Post# of 20689
Re: M710 (probably Xolair)

If the list you posted is correct, then M710 (the codename of the next FoB in the MYL-MNTA partnership to enter the clinic) is presumably Xolair.

MNTA previously disclosed that M710 was for an autoimmune/inflammation indication, and Xolair fits the bill. Also, like Orencia (M834), Xolair is a drug where the number of FoB players will be few. (I'm not aware of another Xolair-FoB program in development, although there may be one.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”